What's in Thiogenesis Therapeutics, Inc.'s pipeline?

Thiogenesis Therapeutics, Inc. has 2 drugs in our index: 0 marketed, 0 filed, 0 in Phase 3, 2 in Phase 2, 0 in Phase 1.

Which companies overlap with Thiogenesis Therapeutics, Inc.'s portfolio?

Top competitors by shared drug class: Ain Shams University, Baxter, Centre Hospitalier Universitaire de Besancon, Pfizer Inc., University Hospital, Grenoble.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/thiogenesis-therapeutics-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Thiogenesis Therapeutics, Inc. — Portfolio Competitive Intelligence Brief

Thiogenesis Therapeutics, Inc. pipeline: 0 marketed, 0 filed, 0 Phase 3, 2 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 0 Phase 3 2 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

No leading-phase drugs tracked for this sponsor.

Therapeutic area mix

Neurology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Ain Shams University · 1 shared drug class
Baxter · 1 shared drug class
Centre Hospitalier Universitaire de Besancon · 1 shared drug class
Pfizer Inc. · 1 shared drug class
University Hospital, Grenoble · 1 shared drug class
University Hospital, Saarland · 1 shared drug class
University of Aarhus · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Thiogenesis Therapeutics, Inc.:

Cite this brief

Drug Landscape (2026). Thiogenesis Therapeutics, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/thiogenesis-therapeutics-inc. Accessed 2026-05-16.